Concepedia

Author

Hidetaka Takashima

Kyoto Prefectural University of Medicine

Also Known As

H. Takashima, HIDETAKA TAKASHIMA, Hidetaka Takashima

22

Publications

614

Citations

9

H-Index

32

Concepts

All Affiliations

Kyoto Prefectural University of MedicineFukuyama City HospitalKyoto first Red Cross hospitalAkashi Municipal City HospitalJapanese Red Cross Society Kyoto Daini Hospital
HT

About

Hidetaka Takashima is an author at Kyoto Prefectural University of Medicine specializing in medicine, pathology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

433

2

Hepatology

3

3

204

3

Cell Biology

2

2

50

4

Immunology

2

2

181

5

Health Sciences

1

1

23

Hidetaka Takashima

×

9

Publications

596

Citations

9

H-Index

YearCitations

A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins

Taichiro Nishikawa, Tomoki Nakajima, Michihisa Moriguchi,

Journal of Hepatology

2005

179

The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin‐8 production

Michihisa Moriguchi, Tomoki Nakajima, Hiroyuki Kimura,

International Journal of Cancer

2002

93

Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis

Masahito Minami, Yukiko Daimon, Kojiro Mori,

Oncogene

2005

88

Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD

Tomoki Nakajima, Michihisa Moriguchi, Tatsuo Katagishi,

Liver International

2005

68

Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular Carcinoma

Aya Takahashi, Michihisa Moriguchi, Yuya Seko,

Anticancer Research

2019

65

Centrosome aberration accompanied with p53 mutation can induce genetic instability in hepatocellular carcinoma

Tomoki Nakajima, Michihisa Moriguchi, Yasuhide Mitsumoto,

Modern Pathology

2004

38

<i>In vivo</i> expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma

Hidetaka Takashima, Tomoki Nakajima, Michihisa Moriguchi,

Liver International

2005

30

Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis

Aya Takahashi, Michihisa Moriguchi, Yuya Seko,

Cancers

2020

23

Tumor size-independence of telomere length indicates an aggressive feature of HCC

Tomoki Nakajima, Tatsuo Katagishi, Michihisa Moriguchi,

Biochemical and Biophysical Research Communications

2004

12

Page 1